Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial
Published Online: 2022-07-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Adolfo García-Sastre•Alicia Solórzano•Bruce L Innis•Bruno Salaun•Carline Vanden Abeele•Corey P Mallett•Céline Verheust•Damien Friel•Dan Bi•Florian Krammer•Frank Struyf•Juliane Koch•Laurence Chu•Marie-Pierre David•Nicolas Folschweiller•Peter Palese•Pierre Van Damme•Raffael Nachbagauer•Ronan Nicolas Rouxel•Valerie Vantomme
